These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 20015461)
1. Obsessive-compulsive disorder with poor insight: a three-year prospective study. Catapano F; Perris F; Fabrazzo M; Cioffi V; Giacco D; De Santis V; Maj M Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):323-30. PubMed ID: 20015461 [TBL] [Abstract][Full Text] [Related]
2. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study. Catapano F; Perris F; Masella M; Rossano F; Cigliano M; Magliano L; Maj M J Psychiatr Res; 2006 Sep; 40(6):502-10. PubMed ID: 16904424 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and treatment response in poor and good insight obsessive-compulsive disorder. Ravi Kishore V; Samar R; Janardhan Reddy YC; Chandrasekhar CR; Thennarasu K Eur Psychiatry; 2004 Jun; 19(4):202-8. PubMed ID: 15196601 [TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. Poyurovsky M; Kriss V; Weisman G; Faragian S; Kurs R; Schneidman M; Fuchs C; Weizman A; Weizman R J Clin Psychiatry; 2003 Nov; 64(11):1300-7. PubMed ID: 14658943 [TBL] [Abstract][Full Text] [Related]
5. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder. Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119 [TBL] [Abstract][Full Text] [Related]
6. Dimensional correlates of poor insight in obsessive-compulsive disorder. Jakubovski E; Pittenger C; Torres AR; Fontenelle LF; do Rosario MC; Ferrão YA; de Mathis MA; Miguel EC; Bloch MH Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1677-81. PubMed ID: 21640153 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up study of patients with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder. Reddy YC; Alur AM; Manjunath S; Kandavel T; Math SB J Clin Psychopharmacol; 2010 Jun; 30(3):267-72. PubMed ID: 20473061 [TBL] [Abstract][Full Text] [Related]
13. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal course of pharmacotherapy in obsessive-compulsive disorder. Grant JE; Mancebo MC; Weinhandl E; Odlaug BL; Eisen JL; Rasmussen SA Int Clin Psychopharmacol; 2013 Jul; 28(4):200-5. PubMed ID: 23587985 [TBL] [Abstract][Full Text] [Related]
15. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report. Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661 [TBL] [Abstract][Full Text] [Related]